Insider Selling: Omega Healthcare Investors Inc (NYSE:OHI) CFO Sells $390,000.00 in Stock

Omega Healthcare Investors Inc (NYSE:OHI) CFO Robert O. Stephenson sold 10,000 shares of Omega Healthcare Investors stock in a transaction that occurred on Friday, August 16th. The shares were sold at an average price of $39.00, for a total value of $390,000.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Shares of NYSE:OHI opened at $39.51 on Thursday. The business’s 50 day simple moving average is $37.46 and its 200-day simple moving average is $36.86. The firm has a market capitalization of $8.47 billion, a price-to-earnings ratio of 13.00, a price-to-earnings-growth ratio of 5.16 and a beta of 0.42. The company has a debt-to-equity ratio of 1.17, a current ratio of 2.78 and a quick ratio of 2.78. Omega Healthcare Investors Inc has a 12 month low of $31.69 and a 12 month high of $40.30.

Omega Healthcare Investors (NYSE:OHI) last announced its quarterly earnings results on Tuesday, August 6th. The real estate investment trust reported $0.34 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $0.73 by ($0.39). The firm had revenue of $191.81 million for the quarter, compared to analysts’ expectations of $190.46 million. Omega Healthcare Investors had a return on equity of 6.79% and a net margin of 29.38%. Omega Healthcare Investors’s revenue was down .5% compared to the same quarter last year. During the same period last year, the firm earned $0.75 EPS. On average, equities analysts anticipate that Omega Healthcare Investors Inc will post 2.95 earnings per share for the current year.

The company also recently declared a quarterly dividend, which was paid on Thursday, August 15th. Stockholders of record on Wednesday, July 31st were paid a dividend of $0.66 per share. This represents a $2.64 annualized dividend and a dividend yield of 6.68%. The ex-dividend date of this dividend was Tuesday, July 30th. Omega Healthcare Investors’s dividend payout ratio (DPR) is 86.84%.

Several large investors have recently made changes to their positions in OHI. Vanguard Group Inc. raised its position in shares of Omega Healthcare Investors by 5.6% during the 2nd quarter. Vanguard Group Inc. now owns 31,995,715 shares of the real estate investment trust’s stock worth $1,175,842,000 after purchasing an additional 1,686,492 shares during the last quarter. BlackRock Inc. raised its position in shares of Omega Healthcare Investors by 2.5% during the 2nd quarter. BlackRock Inc. now owns 24,907,576 shares of the real estate investment trust’s stock worth $915,351,000 after purchasing an additional 600,319 shares during the last quarter. Bank of New York Mellon Corp raised its position in shares of Omega Healthcare Investors by 2.0% during the 2nd quarter. Bank of New York Mellon Corp now owns 5,048,815 shares of the real estate investment trust’s stock worth $185,543,000 after purchasing an additional 98,805 shares during the last quarter. Federated Investors Inc. PA raised its position in shares of Omega Healthcare Investors by 7.6% during the 1st quarter. Federated Investors Inc. PA now owns 3,460,637 shares of the real estate investment trust’s stock worth $132,023,000 after purchasing an additional 243,272 shares during the last quarter. Finally, Invesco Ltd. raised its position in shares of Omega Healthcare Investors by 19.0% during the 2nd quarter. Invesco Ltd. now owns 3,204,955 shares of the real estate investment trust’s stock worth $117,781,000 after purchasing an additional 512,093 shares during the last quarter. 66.86% of the stock is currently owned by institutional investors and hedge funds.

OHI has been the topic of a number of analyst reports. Raymond James raised Omega Healthcare Investors from an “outperform” rating to a “strong-buy” rating and lifted their price objective for the company from $40.00 to $42.00 in a report on Thursday, August 8th. Zacks Investment Research lowered Omega Healthcare Investors from a “buy” rating to a “hold” rating in a report on Wednesday. Six investment analysts have rated the stock with a hold rating, one has given a buy rating and one has issued a strong buy rating to the company. The company presently has a consensus rating of “Hold” and an average target price of $38.77.

Omega Healthcare Investors Company Profile

Omega is a real estate investment trust that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the US, as well as in the UK.

Further Reading: Balanced Fund

Insider Buying and Selling by Quarter for Omega Healthcare Investors (NYSE:OHI)

Receive News & Ratings for Omega Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.